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A B S T R A C T
Copper ion-catalyzed oxidation of yeast SOD1 (ySOD1) was examined to determine early oxidative modifica-
tions, including oxidation of a crucial disulfide bond, and the structural and functional repercussions of these
events. The study used distinct oxidative conditions: Cu2+/H2O2, Cu2+/H2O2/AscH− and Cu2+/H2O2/glucose.
Capillary electrophoresis experiments and quantification of protein carbonyls indicate that ySOD1 is highly
susceptible to oxidative modification and that changes can be detected within 0.1min of the initiation of the
reaction. Oxidation-induced structural perturbations, characterized by circular dichroism, revealed the forma-
tion of partially-unfolded ySOD1 species in a dose-dependent manner. Consistent with these structural changes,
pyrogallol assay indicates a partial loss of enzymatic activity. ESI-MS analyses showed seven distinct oxidized
ySOD1 species under mild oxidation within 0.1min. LC/MS analysis after proteolytic digestion demonstrated
that the copper-coordinating active site histidine residues, His47 and His49, were converted into 2-oxo-histidine.
Furthermore, the Cu and Zn bridging residue, His64 is converted into aspartate/asparagine. Importantly, the
disulfide-bond Cys58-Cys147 which is critical for the structural and functional integrity of ySOD1 was detected
as being oxidized at Cys147. We propose, based on LC/MS analyses, that disulfide-bond oxidation occurs without
disulfide bond cleavage. Modifications were also detected at Met85 and five surface-exposed Lys residues. Based
on these data we propose that the Cys58-Cys147 bond may act as a sacrificial target for oxidants and protect
ySOD1 from oxidative inactivation arising from exposure to Cu2+/H2O2 and auto-inactivation during extended
enzymatic turnover.
1. Introduction
Recent discussions on the underlying neurotoxic mechanisms of
various neurological disorders including ALS [1] have been dominated
by the ‘oxidative stress’ hypothesis. This theory is persuasive in the case
of metalloenzymes as the hypothesis requires redox-active metal ions to
initiate the oxidative reactions that generate reactive oxidants (so-
called ‘reactive oxygen species’, ROS) which promote damage to the
proteins [2,3]. Mounting evidence suggests that the combined effects of
oxidative damage and subsequent aggregation of Cu/Zn-Superoxide
dismutase-1 (SOD1) contribute to the neurodegeneration in the case of
ALS [4–6].
SOD1 is an indispensable homo-dimeric metalloenzyme that cata-
lyzes the dismutation of the superoxide anion, O2•−, to O2 and H2O2
and thereby protects cells against O2•− -dependent damage [7–9].
However, the presence of O2•− and H2O2 within the enzyme active site
also makes SOD1 susceptible to damage, metal ion release, and self-
inactivation [10]. Cu(I) reacts rapidly with H2O2 producing oxygen
radicals [11] that can damage and inactivate SOD1 [10,12]. Such ra-
dical attack may release free copper ions and result in increased gen-
eration of radicals and damage to other proteins.
ALS is a complex, multifactorial and devastating late-onset motor
neuronal disease [1,13] where the majority (~90%) of cases are
sporadic (SALS), with only ~10% due to familial ALS (FALS) [14]. The
complexity of ALS is further increased by a phenotypic overlap between
SALS and FALS, making these difficult to distinguish clinically [4,15].
Over 185 mutations covering 153 amino acids of SOD1 have been de-
scribed to date and associated with FALS cases [16]. While FALS-as-
sociated genetic risk factors provide significant clues about the disease
mechanism [17], ca. 66% of FALS cases are related to mutations in ~15
genes, the most common being SOD1 (20% of FALS cases) [14,16],
followed by FUS and UBQLN2 [16]. The mechanism by which these
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mutations exert neural damage in FALS cases, and the trigger for in-
creased oxidative stress in SALS cases, remain unclear. However, by
analogy with other diseases like Alzheimer's [18,19] and Parkinson's
disease [20], it has been suggested that ALS could be initiated by
misfolded conformations of SOD1, with these leading to aggregation
and inclusion bodies [10,21,22]. Mutant SOD1 proteins have been de-
tected with reduced stability [23,24], reduced metal ion content [25],
or a combination of these [26]. Mutant SOD1 proteins have also been
suggested to generate reactive oxygen species (ROS) or reactive ni-
trogen species (RNS) as a result of the exposure of the copper ion due to
misfolding, with this then participating in oxidative reactions. Fur-
thermore, a more open conformation of SOD1 mutants, compared to
wild-type, may enable interactions with substrates other than super-
oxide at the active site and resulting in aberrant oxidative reactions [4].
Both familial and sporadic cases of ALS have been reported with in-
creased levels of oxidatively-damaged SOD1 protein [27]. Multiple
studies have provided evidence for increased oxidative stress in the
spinal cords of ALS patients, compared to controls, as detected by ele-
vated levels of protein carbonyls [27,28], 3-nitrotyrosine [29] and 8-
hydroxy-2′-deoxyguanosine (8-OHdG) [6]. Due to a large number of
known SOD1 mutations [16] and the link of SOD1 to metal ion dys-
homeostasis [6,30] a clear association between oxidative stress and
disease onset of ALS has been established [4,28,31].
SOD1 harbors a stable intra-subunit disulfide bond which is an
uncommon structural motif in proteins present in the cytoplasm of cells
which contain multiple reducing species [32]. This disulfide bond has
been suggested to maintain stability and quaternary structure
[21,33,34]. Although the requirement of the disulfide bond for the
enzymatic activity of SOD1 is actively debated [10,35], it has been
suggested that this bond is required for full catalytic activity as it an-
chors a positively-charged Arg side chain that guides O2•− into the
active site [3,36]. A recent study of a C57S human SOD1 mutant, which
lacks this disulfide bond, showed that this protein has only 10% of the
activity of wild-type SOD1 [35]. Furthermore, the disulfide bond in
ALS-associated mutants is suggested to be more susceptible to chemical
reduction compared to the wild-type protein [37], leading to a higher
degree of dimer destabilization and aggregation. In addition, immature
ALS SOD1 mutants with a reduced disulfide-bond have been suggested
to play a significant role in the disease [38]. Intact disulfide-containing
apo SOD1 has been shown to be less prone to form amyloid fibrils
compared to disulfide-reduced apo SOD1, and low concentrations of
disulfide-reduced apo SOD1 have also been reported to trigger fi-
brilization of apo SOD1 with an intact disulfide bridge [39,40].
Several molecular studies have focused on elucidating the metal ion
coordination, activity, mutation and structural determinants of metal-
ion binding to SOD1, and the role of metal ion–catalyzed oxidation
(MCO) on SOD1 aggregation/oligomerization [2,39,41–49]. The sig-
nificance of the disulfide bond and the impact of oxidative modification
of this species on SOD1 structure and function has been studied
[35,45,50,51]. However, the early events in SOD1 oxidation and the
explicit impact of oxidative events on the disulfide bond remain to be
clarified.
Previous studies have shown that H2O2 alone can induce misfolding
of SOD1 [2,52]. In this study, we examine the effect of metal ion-cat-
alyzed oxidation using three distinct oxidation systems: Cu2+/H2O2,
Cu2+/H2O2/AscH− and Cu2+/H2O2/glucose. The oxidation induced by
these systems has been examined at various concentrations, and at
various time points ranging from 0.1 to 180min. Furthermore, the in-
tegrity of the disulfide bond is investigated at 0.1 and 60min under
mild oxidative conditions. Saccharomyces cerevisiae Cu/Zn SOD1
(ySOD1) was chosen for study as this has only two Cys residues which
form the disulfide bond. Glucose was included in some reaction systems
because specific lysine (Lys) residues on the SOD1 protein have been
reported to undergo glycation (Maillard) reactions, and SOD1 in-
activation has been reported to occur both in vivo as well as in vitro as a
result of glycation [53,54].
2. Materials and methods
2.1. Reagents
Copper-zinc superoxide dismutase (Cu/Zn-SOD1; EC1.15.1.1) from
the yeast Saccharomyces cerevisiae (ySOD1) was kindly donated by Carl-
Biotech A/S (Copenhagen, Denmark) [3]. The N-terminal methionine of
the ySOD1 protein was cleaved off during purification. Stabilizer-free
hydrogen peroxide (H2O2, 30%) and copper (II) chloride dihydrate
(CuCl2× 2H2O) was supplied by Merck Chemicals GmbH (Darmstadt,
Germany). Ethylenediaminetetraacetic acid disodium salt (2Na-EDTA)
and 3-(N-morpholino) propane-sulfonic acid (MOPS) were obtained
from BDH Ltd. (Poole, England). L-Ascorbic acid and glucose were
supplied by Sigma-Aldrich (St. Louis, MO, USA). All chemicals and
reagents were of the highest purity grade (> 99.5%).
2.2. Solution and protein preparations
Unless noted otherwise, all reactions were buffered with 20mM
MOPS-NaOH (MOPS, pH 7.4) made from the free acid and NaOH. Stock
solutions of oxidants (CuCl2 and H2O2), reductant (ascorbate (AscH−)
and glucose and the chelator (2Na-EDTA) were prepared using MilliQ
water. The stability of the H2O2 stock solution was monitored using its
UV absorbance at 265 nm and a molar extinction coefficient of
10M−1 cm−1 [55]. Purified and lyophilized wild-type ySOD1, pre-
viously stored at −80 °C, was freshly prepared in MOPS. ySOD1 con-
centrations were determined from UV absorbance (Agilent UV–visible
ChemStation) at 258 nm using ε258= 0.38mgmL−1 cm−1 [56]. Solu-
tions were filtered using 0.2 μm syringe filters before use.
2.3. Metal-ion catalyzed oxidation of ySOD1
Wild-type ySOD1 (final concentration 59 μM) was treated with five
oxidation systems (Conditions 1–5) consisting of Cu2+ (142.5 or
285 μM), H2O2 (475 or 950 μM), AscH− (950 μM) and glucose (950 μM)
at the molar ratios described in Table 1. After addition and rapid
mixing, samples were transferred to a 37 °C heating block with aliquots
withdrawn after 3, 5, 15, 30, 60, and 180min, with these added to a
solution of 2mM EDTA to quench the reaction [20]. For the first time
point (0.1min) the reactions were mixed at 22 °C without heating.
Control reactions including non-oxidized ySOD1, or ySOD1 with in-
dividual separate components of the oxidation systems (Cu2+, H2O2,
AscH−, glucose, EDTA) were prepared and removed for analysis at
0.1 min and after 180min at 37 °C (Table 1). All samples used for
analyses were aliquoted and stored at −80 °C as single-use samples (i.e.
no freeze-thaw cycles) after flash freezing in liquid nitrogen.
2.4. Monitoring ySOD1 oxidation by capillary electrophoresis
Capillary electrophoresis (CE) experiments were performed on
Hewlett-Packard 3DCE apparatus (Agilent) equipped with a UV–Vis
diode array detector (200–600 nm) attached to a temperature-con-
trolled water bath. Separations were performed on a 75 cm×0.005 cm
fused silica capillary. The pH, the ionic strength of the buffer and the
voltage were adapted to avoid any modification in the ySOD1 charge
distribution as well as the Joule effect [57]. The CE running conditions
were: temperature of capillary cassette 25 °C, vial holder temperature
15 °C, voltage 25 kV with a typical current of 55 μA. The separation
buffer consisted of 50mM phosphoric acid (Na) (pH 2.1). Capillaries
were rinsed at 93000 Pa with 1M NaOH for 10min followed by 10min
with the Milli-Q water before initial use, and prior to each run, the
capillary was rinsed with 0.1M NaOH followed by the separation buffer
for 3min each. All samples were injected at 5000 Pa for 10 s and
plugged into the capillary by immediate subsequent injection of se-
paration buffer under the same conditions. On-column detection was at
220 nm. CE control and data acquisition were performed using
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ChemStation software (Agilent Technologies).
2.5. Quantification of carbonyl formation on ySOD1
Protein carbonyls were quantified using the OxiSelect™ protein
carbonyl fluorometric assay kit (Cell Biolabs, San Diego, CA, USA), as
described in the manufacturer's instructions, except with the washing
and dilution steps as described previously [20]. Samples (100 μL) along
with a series of standards in duplicate were placed into an optical
bottom 96-well black fluorescence microtiter plate (Thermo Scientific
Nunc, Thermo Fisher). End-point fluorescence spectra were recorded
using λex 485 nm, λem 530 nm on a Molecular Devices SpectraMax M2
instrument (Sunnyvale, CA, USA). With the exception of incubation
steps at defined temperatures, all other steps were performed either on
ice or using a cooled centrifuge. Prior to carbonyl quantification, the
concentration of soluble protein was estimated by the BCA assay [58]
with the data reported as mol of carbonyls per mol protein.
2.6. ySOD1 activity
ySOD1 activity was assessed by its ability to inhibit pyrogallol au-
toxidation [59,60]. Briefly, ySOD1 samples (0.3 μg recombinant pro-
tein) in pH 8.2, 50mM Tris-HCl buffer containing 1.1mM DPTA was
added to pyrogallol (0.2 mM from a stock solution in 10mM HCl) in a
total volume of 3mL, with the absorbance decrease of pyrogallol was
monitored at 420 nm. The SOD activity corresponding to percentage
inhibition of pyrogallol autoxidation was calculated by the following
formula:
= V V
V
V
Vs
SOD activity (U/ml) p s
( p x 0.5)
x t x n
Where;
Vp=Auto-oxidation rate of pyrogallol (control)
Vs=Auto-oxidation rate of samples (native and oxidized samples)
Vt= Total reaction volume (mL)
Vs=Volume of enzyme used for the assay (mL)
n=Dilution fold of the SOD sample
0.5= Factor for 50% inhibition
One unit of SOD activity was defined as the amount required for
inhibiting pyrogallol autoxidation by 50% per min, with specific ac-
tivities calculated for each sample.
2.7. Monitoring structural changes by circular dichroism and SDS-PAGE gel
analysis
Far-UV (178− 260 nm) CD spectra were collected at 25 °C on a
Jasco J-815 spectropolarimeter equipped with a Peltier-element-con-
trolled thermostat. All CD measurements were performed with a spec-
tral bandwidth of 2 nm, a digital integration time of 4 s, and a scanning
speed of 20 nmmin−1 using a 50 μm path length cell. The final spec-
trum was obtained by subtracting the spectrum of the sample buffer
(20mMMOPS-NaOH buffer, pH 7.4) from the mean sample spectrum of
three individual scans using Jasco Spectra Analysis software, with a
Savitzky-Golay algorithm of convolution width 11 applied.
SDS-PAGE was employed to examine oxidation-induced oligomer-
ization. Control samples were collected at 0.1min and 180min and
compared to ySOD1 incubated with Cu2+, H2O2, AscH−, and EDTA
alone for 180min, or aliquots from complete reaction systems collected
at 0.1, 3, 5, 15, 30, 60, and 180min. Sample containing 37.5 μM ySOD1
were heated to 95 °C for 10min. Molecular mass markers (Invitrogen
pre-stained marker 161–036) and samples were electrophoresed using
4–12% NuPAGE Bis-Tris mini acrylamide gels (Invitrogen, Carlsbad,
CA, USA), using the suppliers’ protocol (200 V, 40min) and stained
with Coomassie Brilliant Blue.
2.8. Electrospray ionization mass spectrometry (ESI-MS) analysis of intact
ySOD1
ESI-MS analyses were performed in the positive ion mode on a
SolariX XR Bruker mass spectrometer coupled to a Dionex Ultimate
3000 high-performance liquid chromatography system without a
column. Samples (5 μL) were diluted with 100 μL MeOH (containing
0.1% formic acid) and 100 μL deionized H2O (containing 0.1% formic
acid). Samples were injected using a HyStar_LC system with a flow rate
of 3 μl min−1. The MS was operated at a drying gas temperature of
200 °C and a capillary voltage of 4000 V. The in-source collision energy
was 60 V and the lower and upper excitation event limits were 150 and
4000m/z respectively. Data acquisition and data analysis were carried
out using Compass ftms control and Compass data analysis software,
respectively.
2.9. Identification of modified sites by proteolytic digestion and LC-MS/MS
Samples of ySOD1 (0.93mgmL−1) was subjected to proteolysis
with: LysC + Trypsin; LysC + GluC + Trypsin; or GluC alone. Samples
of ySOD1 (10 μL) were added to 40 μL 8 M urea in 100 mM Tris/HCl pH
8.0 followed by addition of 1 μL LysC (0.2 μg μL−1; Promega) and 3 h
incubation at 21 °C. Subsequently, 350 μL of 21.4 mM Tris/HCl pH 8.0
was added, together with either 2 μL trypsin (0.1 μg μL−1; Promega) or
2 μL trypsin +2 μL GluC (0.1 μg μL−1; Promega) followed by incuba-
tion at 21 °C overnight. Samples of 10 μL ySOD1 (0.93mgmL−1) sub-
jected to proteolysis with GluC only, were added to 40 μL 8M urea in
100mM Tris/HCl pH 8.0, 350 μL 21.4mM Tris/HCl pH 8.0 and 2 μL
GluC (0.1 μg μL−1) followed by incubation at 21 °C overnight. For
Table 1
Molar ratio and experimental conditions used in Cu/Zn-SOD1 oxidation.
Samples Final concentrations in reaction mixture (μM) EDTA (mM)a Molar ratios Time (min)
ySOD1 CuCl2 H2O2 AscH- Glucose (ySOD1:Cu2+:H2O2:AscH−: Glucose)
Control 1 59 0 0 0 0 0 1: 0: 0: 0: 0 0.1 and 180
Control 2 59 285 0 0 0 0 1: 4.8: 0: 0: 0 0.1 and 180
Control 3 59 0 950 0 0 0 1: 0: 16: 0: 0 0.1 and 180
Control 4 59 0 0 950 0 0 1: 0: 0: 16: 0 0.1 and 180
Control 5 59 0 0 0 950 0 1: 0: 0: 0: 16 0.1 and 180
Control 6 59 0 0 0 0 2 1: 0: 0: 0: 0 + 2 mM EDTA 0.1 and 180
Condition 1 59 142.5 475 0 0 2 1: 2.4: 8: 0: 0 0.1, 3, 5, 15, 30, 60, and 180
Condition 2 59 285 475 0 0 2 1: 4.8: 8: 0: 0 0.1, 3, 5, 15, 30, 60, and 180
Condition 3 59 285 950 0 0 2 1: 4.8: 16: 0: 0 0.1, 3, 5, 15, 30, 60, and 180
Condition 4 59 285 950 950 0 2 1: 4.8: 16: 16: 0 0.1, 3, 5, 15, 30, 60, and 180
Condition 5 59 285 950 0 950 2 1: 4.8: 16: 0: 16 0.1, 3, 5, 15, 30, 60, and 180
a Added to terminate the Cu2+-catalyzed reaction after incubation for the time period given in the last column.
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reduction and alkylation, 100 μL of acidified peptide digest samples
were neutralized with 200 μL 1M Tris pH 7.0 followed by addition of
20 μL 200mM DTT and incubation for 1 h at 21 °C. Then, 20 μL of
400mM iodoacetamide was added followed by incubation for 1 h at
21 °C in the dark. All samples were then subjected to solid-phase ex-
traction using StageTip C18 reverse-phase discs packed into pipette tips
(Thermo Fischer Scientific) as described previously [61].
Samples were analyzed on a Bruker Impact II ESI-QTOF (Bruker
Daltonics) mass spectrometer with an on-line Dionex Ultimate 3000
chromatography system (Thermo Fisher Scientific) equipped with an
Acclaim Pepmap C18 Column (15 cm, 300 μm ID). Peptides were eluted
using a solvent gradient over 55min, using acetonitrile with 0.1%
formic acid at a flow rate of 5 μLmin−1. The MS scan range was
150–1500 m/z with a sampling rate of 1 Hz followed by intensity-based
data-dependent MS/MS (TOP3). Database searches with the “depen-
dent peptide” [62,63] feature were performed with MaxQuant v1.6.1.0
[64,65] using the following parameters: enzyme: GluC and/or Trypsin,
with three missed cleavages; 1% peptide-level false discovery rate; mass
tolerance: 0.07 and 0.005 Da (first and main searches, respectively);
MS/MS mass tolerance: 40 ppm (first and main searches); and “de-
pendent peptide” bin size: 0.0065 Da. For alkylated samples, carbami-
domethyl (cysteine) was included as a fixed modification. Subsequent
MaxQuant database searches without the “dependent peptide” feature
were performed with the same parameters, but including variable
modifications corresponding to the mass-shifts detected in the “de-
pendent peptide” search.
2.10. Statistical analysis
Data are presented as the mean ± standard deviations of three
replicates from three independent experiments unless otherwise stated.
Statistical analysis was carried out using the STDEV.P function in Excel.
3. Results
3.1. Low concentrations of H2O2 induce oxidative damages to native
ySOD1
Incubation of 950 μMH2O2 alone with ySOD1 for 0.1 min did not
result in significant alterations to the capillary electrophoresis electro-
pherograms (Fig. S1A), or the CD spectra of the protein (Fig. S1B).
However, samples analyzed after 180min incubation showed a com-
plete loss of the native protein peak in the CE electropherograms (Fig.
S1A), and unfolding of the ySOD1 secondary structure as detected by
CD (Fig. S1B). Inclusion of EDTA (1mM) in these incubations, to pre-
vent oxidation initiated by trace metal ions, had only marginal effects
on the CE and CD data, suggesting that these structural changes are due
to a direct interaction of H2O2 with the ySOD1 (Fig. S1) in agreement
with previous data [2,66,67].
3.2. Oxidation alters the overall structure of ySOD1
ySOD1 was subjected to oxidation using five different conditions as
indicated in the Materials and methods and Table 1 for seven time
points (0.1, 3, 5, 15, 30, 60 and 180min; Fig. 1), then subjected to CE
analysis. The samples from the earliest time point (0.1min; Fig. 1A)
after exposure to condition 1 (142.5 μM Cu2+ and 475 μMH2O2)
showed ~50% loss of intensity of the parent protein peak, and the
formation of two new peaks with migration times of ~14.8 and
15.2min, indicating rapid modification of ySOD1. With the same oxi-
dation conditions and longer incubation periods, the overall pattern of
the peaks remained the same, but with a decrease in intensity (Fig. 1A)
and a complete loss of resolution of the peaks at 14.8 and 15.2min by
60min. With a higher concentration of Cu2+ (285 μM; condition 2,
Fig. 1B), the overall peak behavior and migration times were similar to
condition 1. With higher concentrations of H2O2 (950 μM; condition 3,
Fig. 1C) more significant changes were observed, with nearly 75% loss
of the parent protein peak detected at the earliest time point (0.1min;
Fig. 1C) and detection of a third product peak at 14.3 min along with
the peaks at 14.8 and 15.2min observed in conditions 1 and 2. At
longer incubation times (60min and 180min; Fig. 1C), the intensity of
the peak at 14.2 min increased concomitantly with almost complete loss
of the peaks from native ySOD1 and the species detected at 14.8 and
15.2min. The broadening of the ySOD1 peaks with increasing reaction
time is ascribed to the presence of a heterogeneous mixture of modified
ySOD1 species.
The presence of AscH− in the reaction mixture (condition 4; i.e.
condition 3 with 950 μM AscH−) resulted in a more rapid decrease in
intensity of the peak from native ySOD1 (Fig. 1D). The 0.1min time
point sample showed a 50% loss of intensity, a loss of peak symmetry
and the presence of a shoulder; this peak envelope then showed a slow
decrease in intensity up to 180min (Fig. 1D). The presence of glucose in
the reaction mixture (i.e. condition 3 with 950 μM glucose) resulted in
rapid changes to the parent ySOD1 peak (Fig. 1E), with the overall
migration pattern being similar to condition 3. A decrease in the parent
protein peak intensity of ca. 75% was detected after 0.1min incubation,
together with several discrete peaks with migration times of 13.7, 14.3,
14.8 and 15.2min. At longer incubation times the native ySOD1 peak
along with the peaks at 13.7, 14.8 and 15.2min decreased in intensity,
while the peak at 14.3 min increased in intensity (Fig. 1E).
The electrophoretic mobility of the control samples is illustrated in
the Supplementary Data and Fig. S1. Untreated native ySOD1 protein
migrated as a single peak (Fig. S2B) and no changes were observed after
180min at 37 °C (Fig. S2C). Incubation of the ySOD1 with Cu2+, glu-
cose or EDTA alone for 180min at 37 °C had no effect on peak intensity,
resolution or migration (Figs. S2D, S2F, and S2H). However, almost
complete loss of native of the native ySOD1 peak was observed in the
presence of H2O2, and nearly 50% loss in the presence of AscH− (Figs.
S2E and S2G), indicating that modification of ySOD1 can occur in the
absence of added redox-active metal ions.
3.3. Metal-ion catalyzed oxidation induces formation of protein carbonyls
in ySOD1
The carbonyl levels detected for the control samples (Fig. 1F, Table
S1) ranged from 0.006 to 0.06mol carbonyl per mol ySOD1. Incubation
of ySOD1 with H2O2 or AscH− alone gave carbonyl levels of ca.
0.06mol/mol (Fig. 1F, Table S1). With condition 1 (142.5 μM Cu2+ and
475 μMH2O2), a higher level of carbonylation was detected, with a
maximum yield of carbonyls of 0.126mol/mol detected at 15min
(Fig. 1G). This value decreased at longer incubation times (e.g.
0.086mol/mol at 30min; Fig. 1G, Fig. S3, Table S2). With a higher
Cu2+ concentration (285 μM; condition 2), the 15min sample showed a
similar yield of carbonyls (0.125mol/mol; Fig. 1G) with this level
maintained for the remaining incubation period (Fig. 1G, Table S2).
With higher concentrations of both Cu2+ and H2O2 (285 μM and
950 μM, respectively; condition 3), the highest yield of carbonyls was
observed (0.198mol/mol at 15min; Fig. 1G, Table S2). However, de-
spite the concentration-dependent increase in carbonylation, steady-
state or reduced levels of carbonylation were observed after 15min.
The addition of AscH− (950 μM) reduced the concentration of protein
carbonyls detected, with a maximum concentration of 0.112mol/mol
after 180min incubation, whereas after 15min incubation only
0.097mol/mol of carbonyls (Figs. 1G and S3, and Table S2) were
formed. The presence of glucose in the oxidation system (950 μM;
condition 5) resulted in 0.094–0.103mol/mol of carbonyls with the
highest levels of carbonyls detected after 15min of incubation
(0.137mol/mol; Figs. 1G and S3, and Table S2).
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3.4. Ascorbate protects ySOD1 from formation of dimers and truncated
species
Analysis of control samples (Fig. 2A) indicated the presence of
monomeric ySOD1 as a single band at ~17.5 kDa, together with very
low levels of a species assigned to a ySOD1 dimer at ~35 kDa. In-
cubation of ySOD1 with H2O2 alone (Fig. 2A) or AscH− (Fig. 2A) re-
sulted in the detection of a broad smear on the gels between 10 and
20 kDa consistent with the presence of a large number of heterogenous
modified forms of the protein. These data are consistent with the
multiple peaks detected by CE analysis, and the increased carbonyl
levels detected for these samples. For ySOD1 exposed to reaction system
1 (Fig. 2B), a dimeric band similar to that seen with native ySOD1 was
detected but at higher intensity, but increasing incubation time did not
alter the levels of this species (Fig. 2B), however, two weak protein
bands at lower apparent mass (~12 and ~10 kDa), possibly due to the
formation of truncated/fragmented species, were detected at longer
reaction times (Fig. 2B). At higher levels of Cu2+ (285 μM) a more
pronounced dimeric band was detected, together with a reduced in-
tensity of the lower mass species (Fig. 2C). However, with high levels of
both Cu2+ (285 μM) and H2O2 (950 μM) increased intensities of the
fragment bands at ~12 and ~10 kDa were detected, together with a
time-dependent loss of the dimer protein band (Fig. 2D). ySOD1 sam-
ples incubated under condition 4 in the presence of AscH− (Fig. 2E),
showed an almost complete loss of the dimer and truncated SDS bands
detected. In contrast, the presence of glucose gave rise to higher levels
of the dimer species, as well as multiple discrete lower molecular mass
bands at ~15, ~12, ~10, and ~8 kDa. The intensity of these bands
decreased with increasing incubation time (Fig. 2F).
3.5. Oxidation induces changes in the secondary structure of ySOD1
Far-UV CD spectra for control and selected oxidized samples are
shown in Fig. 3 whereas an overlay of CD spectra showing all controls
and oxidized samples are presented in Fig. S4. With the exception of
ySOD1 mixed with H2O2, all control samples showed a positive band at
approximately 195 nm and a broad minimum at ~210 nm, typical of a
β-sheet-rich protein structure. In contrast, incubation with
950 μMH2O2 alone (Fig. 3A) resulted in a complete loss of the positive
band at 195 nm and additional changes between 222 and 225 nm. For
reaction condition 1, the positive band at 195 nm showed a decrease in
intensity with increasing reaction time (Fig. 3B) and especially over the
first 30min (Fig. S4B). When the Cu2+ concentration was raised in
condition 2, perturbations in the CD spectra at 222 nm increased,
whereas changes in the positive band at 195 nm were similar to those
detected with condition 1 (Figs. 3C and S4C). The most marked changes
were observed with the highest Cu2+ and H2O2 concentrations (con-
dition 3) with a marked, time-dependent loss of the positive band at
195 nm, and a shift in the CD-signal towards 200 nm, observed, in-
dicative of an increased unfolding of the ySOD1 secondary structure as
a function of time (Figs. 3D and S4D). In the presence of AscH− (con-
dition 4) a time-dependent decrease in the positive band at 195 nm was
detected, but to a much smaller extent than seen with condition 3, and
the shift of the CD-signal towards 200 nm was absent (Figs. 3E and
S4E). An increase in a positive band at wavelengths above 230 nm was
also detected at 180min. In the presence of glucose (condition 5), the
spectral changes were similar to those observed in condition 3, though
to a less marked extent at 180min, with significant decreases at 195 nm
and a shift towards 200 nm detected (Figs. 3F and S4F).
3.6. Metal-ion catalyzed oxidation impacts on the enzymatic activity of
ySOD1
Native ySOD1 showed 11.6 kU/mg of specific enzyme activity when
assayed using pyrogallol (Fig. 4A, Table S3). The activity detected for
ySOD1 incubated with one component of the reaction system (Cu2+,
H2O2, AscH−, glucose, EDTA individually) ranged between 65 and 98%
of the native activity (Fig. 4A), with the exception of the H2O2 system
Fig. 1. Time-dependent capillary electrophoresis
electropherograms and carbonyl quantifications
of ySOD1 under various oxidative conditions.
Overlayed CE electropherogram profiles of 59 μM of
ySOD1 subjected to oxidation using (A) Condition 1,
(B) Condition 2, (C) Condition 3, (D) Condition 4,
and (E) Condition 5. Absorbance detection was car-
ried at 220 nm. (F) Protein carbonyls determined for
all control reactions including unoxidized (native)
ySOD1 (grey), mixture of ySOD1 with Cu2+ (red),
H2O2 (blue), EDTA (orange), AscH− (pink) and glu-
cose (green) incubated at two time–points, 0.1 min
and 180min. (G) Time–course of protein carbonyl
formation at six–time points (0.1, 3, 5, 15, 30, and
60min). Condition 1 (black line), condition 2 (red
line), condition 3 (blue line), condition 4 (pink line),
and, Condition 5 (green line). Protein carbonylation
levels are given in mol/mol and the data points and
error bars represent the mean and standard deviation
of triplicate technical replicates from two in-
dependent experiments. Except for 0.1min, all other
MCO reaction mixtures were incubated at 37 °C for
the time shown. (For interpretation of the references
to color in this figure legend, the reader is referred to
the Web version of this article.)
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which resulted in a 90% loss of activity at 0.1min, and a further small
decline by 180min (Fig. 4A).
With reaction condition 1 (142.5 μM Cu2+ and 475 μMH2O2),
ySOD1 activity was reduced to 55% at the earliest time point (0.1min)
and this activity remains constant for the entire 180min period
(Fig. 4B, Table S4). With a higher Cu2+ concentration (285 μM) lower
levels of activity (33–39% of control) were detected at 0.1 and 3min,
but the activity recovered at longer time points to give a plateau value
of ~75% of the native ySOD1 activity (Fig. 4C, Table S4). Condition 3
(285 μM Cu2+ and 950 μMH2O2) resulted in the lowest levels of ac-
tivity at the 0.1min time point (~16%) with the activity again re-
covering to a modest extent at longer times (Fig. 4D, Table S5). In the
presence of AscH− (950 μM), similar data was obtained to that seen
with condition 2, with an activity of ~50% at all time points (Fig. 4E,
Table S4). The presence of glucose (950 μM) resulted in a low level of
activity after 0.1min (~35%) and a further slow decline with in-
creasing incubation time (Fig. 4F, Table S4).
3.7. ESI–MS analysis of intact ySOD1 indicates formation of multiple
oxygenated species
ESI–MS analysis of native ySOD1 showed a charge envelope from
+12 to +18 (Fig. S5), with the +15-charge base peak state (mono-
isotopic m/z 1048.47; Fig. 5A), yielding a deconvoluted mass of
15712.91 Da consistent with the theoretical mass of the disulfide-linked
species lacking the N-terminal methionine (15712.81 Da). In addition,
four minor species were detected with experimental m/z values of
1049.53, 1050.53, 1055.00, and 1062.41 (Fig. 5A, Table S5) with these
assigned to the addition of 1O (+16.05 Da), 2O–H (+31.07 Da), H2SO4
(+98.03 Da) and MOPS (+209.17 Da), respectively.
With ySOD1 exposed to reaction condition 1 (285 μM Cu2+ and
475 μMH2O2), shifts in the mass spectrum consistent with the presence
of multiple oxidized ySOD1 species were detected after 0.1 min
(Fig. 5B). In addition to the prominent peak from unmodified ySOD1
(see above), seven distinct signals were observed with experimental
monoisotopic m/z values of 1049.53 (15728.86 Da, +16 Da, i.e. one
oxygen, 1O), 1050.60 (15744.87 Da, +32 Da, 2O), 1051.67
Fig. 2. SDS–PAGE analyses of control and oxidized ySOD1 under different oxidative conditions. Samples were prepared as indicated in the Materials and
methods. Control and oxidized ySOD1 samples under various conditions are organized on each SDS gel (A to F). Whereas gel (A) organized with control samples; lane
M, molecular mass markers; lane – 1, native ySOD1; lane – 2, ySOD1 incubated at 37 °C for 180min; lane – 3, ySOD1 incubated with Cu2+ at 37 °C for 180min; lane –
4, ySOD1 incubated with EDTA at 37 °C for 180min; lane – 5, ySOD1 incubated with H2O2 at 37 °C for 180min; lane – 6, ySOD1 incubated with glucose at 37 °C for
180min; lane – 7, ySOD1 incubated with AscH− at 37 °C for 180min. (B) Condition 1, (C) condition 2, (D) condition 3, (E) condition 4, and (F) condition 5. The left-
hand side lane on each gel contains molecular mass markers.
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Fig. 3. Overlay of far-UV CD spectra for selected control and oxidized ySOD1 under different oxidative conditions. (A) CD spectra for the control reactions
including 59 μM of untreated ySOD1 in 20mM MOPS buffer pH 7.4 (black line), ySOD1 incubated at 37 °C for 180min (red line). Mixture of 59 μM ySOD1 incubated
at 37 °C for 180min with 285 μM Cu2+ (blue line), 950 μMH2O2 (magenta line), and 2mM EDTA (olive line), separately. (B) Condition 1, (C) condition 2, (D)
condition 3, (E) condition 4, and (F) condition 5. The color lines in panel B to F shows untreated ySOD1in black line whereas 0.1min (red), 5 min (blue), 15min
(cyan), and 180min (dark yellow). Except for untreated ySOD1 and 0.1min reactions, all other MCO reaction mixtures were incubated at 37 °C. Complete overlay of
all spectra including AscH− and glucose controls and oxidation data obtained after 0.1, 3, 5, 15, 30, 60 and 180min, are shown in Supplementary Fig. S3. (For
interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Fig. 4. The time-dependent activity of ySOD1 of control and oxidized ySOD1 under different oxidative conditions. The native ySOD1 showed 11.6 kU/mg of
specific enzyme activity when subjected to the pyrogallol auto-oxidation assay. This value was considered to be 100% ySOD1 activity for the comparison with other
control and oxidized samples. (A) ySOD1 activity determined for all control reactions including unoxidized (native) ySOD1 (grey), mixture of ySOD1 with Cu2+
(red), H2O2 (blue), EDTA (orange), AscH− (pink) and glucose (green) incubated at two time–points, 0.1 min and 180min. (B) Condition 1, (C) condition 2, (D)
condition 3, (E) condition 4, and (F) condition 5. Error bars represent the mean and standard deviation of data from three independent experiments. (For inter-
pretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
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(15760.59 Da, +48 Da, 3O), 1052.73 (15776 Da, +64 Da, 4O),
1053.80 (15792.84 Da, +80 Da, 5O). Detailed analysis of the mass
spectra representing monoisotopic m/z value of 1054.93 (15809.82 Da,
+97 Da) suggested overlapping features from a mixture of 96 Da (6O
and 1H) +98 Da (H2SO4) species. An additional species was observed
with m/z 1056.06 (15826.82 Da, +114 Da, 7O and 2H), with the ad-
dition of 2 hydrogen atoms in this species consistent with cleavage of
the disulfide bond with the incorporation of 7 O atoms. Additional
adducts of protonated ySOD1 with MOPS (m/z 1062.41) and proto-
nated and oxidized ySOD1 with MOPS (m/z 1063.47) were also de-
tected (Fig. 5B, Table S6). Further incubation under the same reaction
conditions (condition 1) yielded identical mass shift patterns, and loss
of 1–2 hydrogen atoms were also observed (Fig. S6A- S6D; Table S6).
With the higher Cu2+ concentrations of condition 2 (Table 1), the
monoisotopic m/z distributions were identical to those detected from
condition 1 at reaction times of 0.1min (Fig. 5C), 3 min and, 5min
(Figs. S7A and S7B and, Table S7). The spectra detected from the 15-
and 60-min samples, despite showing similar ions assigned to the in-
corporation of 1–7 oxygen atoms, were of much lower relative intensity
(Figs. S7C and S7D and, Table S7). Low-intensity mass peaks with a
mass loss of −15 Da, – 30 Da and – 47 Da were also detected (Fig. S7,
Table S7)
The results from condition 3 (high Cu2+ and high H2O2) are shown
in Fig. 5D, and Fig. S8 and corresponding masses are summarized in
Table S8. The mass spectra analyzed at each time point show major
peaks related to both unmodified ySOD1 and oxygen atom adducts with
a significant loss of ion intensity. With the addition of AscH− a similar
m/z distribution of oxygen atom adducts to ySOD1 was detected with
moderate loss of the ion intensities as a function of time (Figs. 5E and
S9, and Table S9). The presence of glucose in the reaction mixture
(condition 5) resulted in a marked loss of ion intensities from both
unmodified and modified ySOD1 species (Figs. 5F and S10 and Table
S10). The corresponding masses summarized in Table S10 are con-
sistent with the presence of native ySOD1 with one to seven oxygen
atoms added. However, in the presence of glucose, the MS signal also
indicates the formation of a hydroxyl group with a gain of 1 H as well as
cleavage of the disulfide bond.
3.8. Peptide mass mapping reveals sites of modification in ySOD1
Protein digests were analyzed by LC-MS/MS to identify specifically
modified peptides in ySOD1 exposed to the mild oxidation system
(condition 1) for 0.1 and 60min as well as in untreated ySOD1. The
mass shifts detected were mainly associated with modifications at His,
Met, Lys and the Cys residues from the disulfide bond (Table 2). Specific
residues detected as modified include the Cu ion coordinating His re-
sidues (H47, H49, and H64), a number of exposed Lys (K70, K97, K101
and K106), Met (M85) and the Cys residues (C147 and C58) (Fig. 6)
from the intramolecular disulfide bond; most of these modifications,
including oxidation of C147 to sulfinic and sulfonic acids were only
Fig. 5. Positive ion ESI–MS spectra of native and oxidized ySOD1 showing +15 charged species under various oxidative conditions. (A) Native ySOD1, (B)
Oxidized ySOD1 for 0.1min under condition 1, (C) oxidized ySOD1 for 0.1 under condition 2, (D) oxidized ySOD1 for 0.1min under condition 3 (E) oxidized ySOD1
for 0.1min under condition 4 and (F) oxidized ySOD1 for 0.1min under condition 5. The m/z values indicated are monoisotopic masses.
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detected in the modified samples and not the controls (Fig. 6A–C). The
formation of the C147-derived species may occur as a result of sec-
ondary reactions following oxidation of the initial disulfide to thio-
sulfinate or thiosulfonate forms. Assessment of the LC-MS data from
proteolytic digests performed under non-reducing conditions revealed
several oxidized forms of the disulfide-containing dipeptide, but it was
not possible to unambiguously assign these mass shifts. However, we
observed that the single peptide containing an oxidation of C147 to a
sulfinic acid (138TGNAGPRPAC*GVIGLTN154) co-elutes with signals
displaying spectral features of a disulfide-linked peptide (Fig. 6D–F).
This may indicate that the disulfide bond is subjected to “in-source”
reduction in the mass spectrometer, a phenomenon reported previously
[68].
4. Discussion
Two major mechanisms have been suggested to rationalize the
toxicity of SOD1-associated FALS mutations. These are: i) structural
destabilization of the SOD1 architecture including decreased stability of
SOD1 monomer and increased dimer destabilization and, ii) altered
catalytic properties. Increasing experimental evidence suggests that the
molecular interplay of oxidative stress with a decreased integrity of the
disulfide bond could be of critical importance in initiating unfolding
and aggregation of SOD1 [23,28,69]. The current study therefore ex-
amined the hypothesis that early oxidative modification of ySOD1, in-
cluding oxidation of the crucial disulfide bond, may perturb the
structural and functional properties of this enzyme.
4.1. H2O2 derived oxidative damages to native ySOD1 is a slow process
Compared to previous studies where mM concentrations of H2O2
and long incubation periods were employed to induced structural and
functional perturbations [2,52,70], we have shown that exposure of
ySOD1 to 950 μMH2O2 alone for 180min at 37 °C could induce sig-
nificant oxidative modifications, and that the metal ion chelator EDTA
had only a marginal effect on these H2O2-derived changes (Fig. S1).
Although, the H2O2 levels used in this study (950 μM) do not mimic
physiological steady-state levels (10–100 nM) [71], the use of excess
H2O2 allows the study of accelerated reactions over a reasonable ex-
perimental time scale, that may mimic the long term development of
the human disease, where continued exposure to lower levels of H2O2
will occur over many years. Previous studies that have proposed that
H2O2 can rapidly reduce enzyme-bound Cu2+ to Cu+ [66,67], with this
followed by a Fenton-like reaction in the presence of additional H2O2
[67], resulting in oxidation of the active site His residues and metal-ion
release [2,72]. In line with these previous observations of oxidative
modifications [66,67,72] including structural rearrangements
[2,52,70], our study indicates that H2O2 alone can increase the yield of
protein carbonyls, decrease enzyme activity and induce structural re-
arrangements (vide infra). However, it is important to note that these
effects of H2O2 on ySOD1 observed at long incubation times may be of
limited biological relevance as H2O2 is very rapidly turned over by
Table 2
Oxidatively-modified peptides in ySOD1 identified by LC-MS/MS-based detection. The peptides were generated by proteolytic digestion of reduced and alkylated
ySOD1 with either trypsin or GluC or a mixture the two enzymes as described in the methods section. LC-MS/MS peptide mapping was carried out on control
(untreated) and Cu2+/H2O2 treated ySOD1 after 0.1 and 60min incubations. Amino acid residues are numbered according to UniProtKB database id (P00445) for
Saccharomyces cerevisiae (strain ATCC 204508/S288c) (Baker's yeast) SOD1. *GluC #Trypsin*# Trypsin/GluC.
Sites Sequence position/Peptide$ Ctrl 0.1 min 60min Δm Comp. Products/Modifications
H47 35IAGNSPNAERGFHIHE50* – ✓ – 15.99 O(1) 2-oxo histidine
H49 35IAGNSPNAERGFHIHE50* – ✓ – 15.99 O(1) 2-oxo histidine
H49 35IAGNSPNAERGFHIHE50* – ✓ – 47.98 O(3) Trioxidation
H49 44RGFHIHE50* – ✓ – 16 O(1) 2-oxo histidine
H49 44RGFHIHE50* – ✓ – 47.99 O(3) Trioxidation
H64 51FGDATNGCVSAGPHFNPFKKTHGAPTDE78* – ✓ – −23.02 H(-1) C(-2) N(-1) O(1) His-> Asn
H64 51FGDATNGCVSAGPHFNPFKKTHGAPTDE78* – ✓ – −22.03 H(-2) C(-2) N(-2) O(2) His-> Asp
H64 45GFHIHEFGDATNGCVSAGPHFNPFKK70# – ✓ ✓ −22.02 H(-2) C(-2) N(-2) O(2) His-> Asp
H64 45GFHIHEFGDATNGCVSAGPHFNPFKK70# – ✓ ✓ −23.02 H(-1) C(-2) N(-1) O(1) His-> Asn
H64 51FGDATNGCVSAGPHFNPFKK70*# – – ✓ −23.02 H(-1) C(-2) N(-1) O(1) His-> Asn
K70 70KTHGAPTDEVR80*# – ✓ – 27.01 H C N
K70 70KTHGAPTDEVR80# – – ✓ 27.01 H C N
M85 79VRHVGDMGNVKTDE92* ✓ ✓ ✓ 15.99 O(1) Methionine sulfoxide
M85 81HVGDMGNVK89# ✓ ✓ ✓ 15.99 O(1) Methionine sulfoxide
M85 81HVGDMGNVK89*# – – ✓ 15.99 O(1) Methionine sulfoxide
M85 81HVGDMGNVK89*# – – ✓ 31.99 O(2) Methionine sulfone
M85 81HVGDMGNVKTDENGVAK97*# ✓ ✓ ✓ 15.99 O(1) Methionine sulfoxide
M85 79VRHVGDMGNVK89*# – ✓ ✓ 15.99 O(1) Methionine sulfoxide
M85 79VRHVGDMGNVK89*# – ✓ ✓ 31.99 O(2) Methionine sulfone
M85 79VRHVGDMGNVKTDE92*# – ✓ ✓ 16.00 O(1) Methionine sulfoxide
K97 90TDENGVAKGSFKDSLIK106# – – ✓ 14.97 H(-3) N(-1) O(2)
K97 90TDENGVAKGSFK101# – – ✓ −19.04 H(-5) N(-1)
K97 90TDENGVAKGSFKDSLIK106# – – ✓ −19.04 H(-5) N(-1)
K97 90TDENGVAKGSFK101*# – – ✓ −19.04 H(-5) N(-1)
K97 90TDENGVAKGSFK101*# – – ✓ 14.96 H(-3) N(-1) O(2)
K101 98GSFKDSLIK106 – ✓ – 58.01 H(2) C(2) O(2) Carboxymethyllysine
K101 98GSFKDSLIK106 – ✓ – 58.01 H(2) C(2) O(2) Carboxymethyllysine
K106 102DSLIKLIGPTSVVGR116# – – ✓ −31.04 H(-5) C(-1) N(-1) Lys-> Pro
K106 102DSLIKLIGPTSVVGR116# – – ✓ −13.03 H(-3) C(-1) N(-1) O(1)
K106 102DSLIKLIGPTSVVGR116*# – – ✓ −31.04 H(-5) C(-1) N(-1) Lys-> Pro
K106 102DSLIKLIGPTSVVGR116*# – – ✓ −13.03 H(-3) C(-1) N(-1) O(1)
C147 138TGNAGPRPACGVIGLTN154# – ✓ ✓ −25.03 $Dioxidation
C147 138TGNAGPRPACGVIGLTN154# – ✓ ✓ −9.04 $Trioxidation
C147 138TGNAGPRPACGVIGLTN154*# – ✓ ✓ −25.03 $Dioxidation
C147 138TGNAGPRPACGVIGLTN154*# – – ✓ −9.04 $Trioxidation
$ Peptides identified in samples subjected to proteolysis with GluC*, trypsin# or a combination of GluC and trypsin *#.
$The analysis is based on the reduced and alkylated samples and therefore we used carbamidomethylation (+57 Da) as a fixed modification of cysteine. This has to be
taken into consideration for the cysteine residues. For example, a cysteine mass shift of −25 Da, means 57–25 = +32 Da relative to unmodified cysteine.
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multiple protective enzymes in vivo (e.g. by members of glutathione
peroxidases, peroxiredoxins and catalase) [73]. However, it is worth
noting that H2O2 can transverse membranes freely [74], and this factor,
combined with the high abundance of SOD1 protein in motor neurons
and the long half-life of this protein (~1.5 years) [75], may allow the
long-term accumulation of oxidative SOD1 damage. Furthermore, there
is emerging evidence that both metal-ion free (apo) and metal-deficient
SOD1 mutants may contribute to SOD1's toxicity [76,77], and it has
been suggested that exogenous supply of copper to these species may
reduce SOD1 pathogenicity [78]. Thus, studies on the early oxidation
events arising from the use of a complete system (Cu2+/H2O2), as re-
ported in the current study, may help shed light on the molecular in-
terplay of Cu2+ and H2O2 in SOD1-associated ALS progression and
prevention.
4.2. Early oxidative events result in alterations in the net charge and
conformation of ySOD1
The electropherograms from conditions 1 and 2 (Fig. 1A and B)
indicate a rapid and significant loss of native ySDO1 at the earliest time
examined (0.1min) and the presence of two additional peaks with in-
creased retention time, indicating the presence of protein species with
different charge and/or conformation. These species disappeared with
increasing incubation time. Oxidative conditions with high levels of
Cu2+ and H2O2 (condition 3, Fig. 1C) and with the addition of glucose
(condition 5; condition 3 + glucose, Fig. 1F) resulted in different
electropherograms with a new peak detected at shorter retention times
indicating a different heterogeneous mixture of oxidized ySOD1 species
under these conditions. Interestingly, the peaks with decreased reten-
tion time showed a continuous increase in the peak intensity over the
entire incubation period and likely represent new specific modifications
(Fig. 1C and E). The presence of AscH− in condition 4 had a marked
effect (Fig. 1D), with a decrease in the native ySOD1 peak and forma-
tion of a peak different to those observed in the absence of AscH−.
AscH− is known to have both pro- and anti-oxidant effects on Cu2+-
catalyzed oxidative reactions [20], and has been suggested to limit non-
specific oxidation of bovine SOD1 [79] and α–Synuclein [20]. Overall,
these data indicate that a mixture of oxidized ySOD1 species are pro-
duced in rapid succession during the reaction. The changes in retention
time in response to oxidation may be attributed to altered net charge
and/or conformation of ySOD1, and it is interesting to note that the
ALS-associated SOD1 mutations G37R, H46R, G85R, D90A, G93R,
E100G, E110K, and D101 N are reported to decrease the overall net
charge whereas V7E tend to increase the net charge [39,69]. Further-
more, heterodimerization studies on some of these mutations have
observed changes in the electrophoretic mobility [80]. By analogy to
the properties of ALS associated mutations, we suggest that early oxi-
dative modifications of wild-type ySOD1 may be a unifying mechanism
that links sporadic and familial cases.
Fig. 6. Oxidative modification sites of the ySOD1 protein. Extracted ion
chromatograms of the doubly charged precursor ion with m/z 815.4 matching
the peptide 138TGNAGPRPACGVIGLTN154 with dioxidation at C147 in SOD
digested with trypsin and Glu-C. (A) Untreated native ySOD1, MCO samples
exposed to condition 1 for 0.1min (B) and, 60min (C). (D) Mass spectrum of co-
eluting species matching the peptide 138TGNAGPRPACGVIGLTN154 with diox-
idation at C147 (m/z 815.4) and the disulphide bonded peptide 45FGDATNG-
CVSAGPHFNPFKK70-S-S-138TGNAGPRPACGVIGLTN154 with mass shifts of
+30 Da (m/z 930.43), +48 Da (m/z 934.94) and +64 Da (m/z 938.94) in SOD
sample exposed to MCO for 0.1min and digested with trypsin and GluC. (E)
MS/MS spectrum of the doubly charged precursor ion with m/z 815.4. (F) MS/
MS spectrum of the doubly charged precursor ion with m/z 934.94. (G)
Oxidized residues are shown as spheres where the active site histidine residues
(H47, H49, and H64) are in blue color, whereas disulfide-linked cysteine (C58
and C147) residues are in yellow color, oxidized methionine (M85) in magenta
color and lysine (K70, K89, K97, K101, and K106) residues are in grey color.
Amino acid residues are numbered according to UniProtKB database id
(P00445) for Saccharomyces cerevisiae (strain ATCC 204508/S288c) (Baker's
yeast) SOD1. The ySOD1 structure is from Saccharomyces cerevisiae (strain ATCC
204508/S288c) (PDB ID code 1B4L [3]) as rendered in Discovery Studio vi-
sualizer 4.0 (51). (For interpretation of the references to color in this figure
legend, the reader is referred to the Web version of this article.)
M.K. Tiwari, et al. Redox Biology 26 (2019) 101262
10
4.3. Carbonylation represents a broad marker of oxidative stress in ySOD1
The quantification data for carbonyl formation show the maximum
yield is generated within 15min of initiation of the reactions under all
the conditions examined (Table S2), indicating that the generation of
these modifications on ySOD1 is rapid. The highest carbonyl yield
(~0.2mol carbonyl/mol ySOD1) was obtained with the highest con-
centrations of Cu2+ and H2O2 (condition 3; Tables 1 and S2 and
Fig. 1G). With the same concentration of Cu2+ but half the H2O2, the
carbonyl levels were reduced to ~0.13mol carbonyl/mol ySOD1 sug-
gesting that the H2O2 concentration is a major driver of the extent of
oxidative modification of ySOD1. This conclusion is supported by the
significant increase in carbonyls detected when H2O2 alone was in-
cubated with ySOD1, compared to ySOD1 with Cu2+ alone (Table S2,
Fig. 1F). These observations are in agreement with a previous study
where the exogenous supply of Cu2+, Fe2+, or metal chelator DTPA did
not alter H2O2-driven carbonylation of bovine SOD1 (bSOD1) [42].
Under the conditions studied here, the carbonyl levels detected were
higher in the presence of Cu2+ alone, compared to its absence, but the
carbonyl yield was not sensitive to the addition of higher levels of Cu2+
over the range studied (Fig. S3).
A previous study of bSOD1 has reported maximum carbonylation in
reaction mixtures containing 30 μM Cu2+, 1mMH2O2, and 5mM
AscH− [42]. However, we found that 285 μM Cu2+, 950 μMH2O2, and
950 μM AscH− resulted in lower levels of carbonyls throughout the
entire incubation period (Table S2, Fig. 1G) when compared to condi-
tion 3. The difference in carbonyl levels may be due to differences in the
stoichiometry of the oxidants and reductants used [81]. Nevertheless,
the low level of carbonyls detected in the presence of AscH− are con-
sistent with its role as an oxidant scavenger as described earlier
[20,82,83]. In the presence of glucose (condition 5), slightly higher
levels of carbonyls were detected throughout the entire incubation
period (Table S2, Fig. 1G) compared to condition 4. This may be due to
glycation reactions, which can give rise to adducted sugar-derived
carbonyls on the protein, or a release of Cu ions from the ySOD1 and
subsequent enhanced Fenton-like reactions [84]. In all conditions, the
carbonyl levels detected either attained a steady-state level after
10–15min incubation or decreased at longer incubation times. Similar
behavior has been reported for α-synuclein [20], bovine serum albumin
(BSA) [85] and β-lactoglobulin [86]. This may be due to further oxi-
dation of these species into carboxylic acids via reaction with H2O2 or
auto-oxidation [87], or as a result of the reaction of the carbonyls with
nucleophiles (e.g. Lys) to give cross-links and Schiff base species [86].
Thus, the relatively high numbers of Lys residues (10) present in ySOD1
may participate in secondary reactions that limit a further increase in
carbonyl production over time. Although protein carbonyl levels are a
widely accepted biomarker of oxidative stress, the current data confirm
previous suggestions [88] that these species should only be considered
as a broad (generic) marker of damage. Furthermore, it is well estab-
lished that other amino acid side-chains, including sulfur- (Cys, Met),
and aromatic residues (Trp, Tyr, His) can be more rapidly and readily
oxidized [20,73], thus, an increase in absolute carbonyl concentration
may represent a late event in disease-derived protein dysfunction.
4.4. Oxidation-induced modifications result in partially unfolded ySOD1
species
Small changes were seen for the ySOD1 samples examined by
SDS–PAGE (Fig. 2). The observation of low-intensity dimer bands under
condition 1, and a slight increase in the intensity of these bands under
harsher conditions (condition 2, 3 and 5) suggests that non-reducible
covalent crosslinks are formed between SOD1 monomers. The same
conditions also resulted in the detection of several low-intensity bands
of lower mass than the parent ySOD1. The detection of these species are
consistent with studies that have mapped the fragmentation pattern of
bSOD1in the presence of Cu2+ and H2O2 [42] as well as glucose [53] in
the case of hSOD1. These data indicate that μM concentrations of H2O2
or glucose, in the presence of Cu2+, are sufficient to induce fragmen-
tation of ySOD1, in addition to the mM concentrations employed pre-
viously [2,42,53]. The presence of AscH− (condition 4) inhibited both
the dimer and fragment bands of ySOD1, an observation in contrast to
the Cu2+-dependent AscH−/H2O2-mediated fragmentation observed
with bSOD1 [42].
Further insight into the structural changes induced by oxidation was
obtained through far-UV CD spectroscopy. Our data support previous
observations that H2O2 alone can induce partial unfolding of SOD1
(Figs. 3A and S1B) and that this occurs with considerably lower con-
centrations than those employed previously [2,89]. However, the pre-
sence of Cu2+ or AscH− with the same amount of H2O2, resulted in less
significant structural changes (vide infra). The gradual decline in posi-
tive intensity between 190 and 210 nm observed under all conditions
(Fig. 3B–F) is indicative of major alterations to the secondary structure
of the protein, and this was more pronounced with increased incubation
time as well as with increased concentrations of oxidants and re-
ductants, i.e., harsher oxidative conditions. These structural re-
arrangements induced by oxidation appear to be distinct from the fully
unfolded state and are of interest as mounting evidence indicates that
partially folded SOD1 subunits are a likely common factor in ALS pa-
thology [23,90]. The structural destabilization hypothesis, which ra-
tionalizes the widespread distribution of ALS mutation sites, provides a
unifying mechanism of toxicity [23]. Whilst protein carbonylation may
contribute to this structural destabilization, the data indicate that a
maximum of 15% of the ySOD1 molecules are carbonylated under the
conditions employed. Although a recent computational simulation
study combined with thermodynamic integration suggests that oxida-
tive damage to even a single residue at the dimeric interface might
destabilize the SOD1 homodimer and monomer, and result in partial
unfolding [24], it is unlikely that carbonyl formation is the sole cause of
the observed changes in structure.
A second potential contributing factor is oxidative modifications to
the amino acids of the metal ion binding loop regions. The Greek key β-
barrel [91] fold of SOD1 has been suggested to be important for the
high structural stability of the enzyme, and its rapid catalysis [23]. In
fact, an ALS-associated β-barrel residue FALS mutant (H43R, hSOD1
numbering) has been shown to rapidly form fibrillar aggregates due to
perturbation of the β-barrel fold and increased monomerization [92]. In
the current study, we have identified conversion of the two β-barrel
active site His residues (H47 and H49; H46 and H48 in hSOD1) into 2-
oxo-His. A third His (H64; H63 in hSOD1) outside the β-barrel, which
forms a bridge between Cu and Zn ions, was also observed to be con-
verted into Asp or Asn (Fig. 6 G-H, Table 2). These His modifications are
consistent with previous studies [2,22,52,70,89]. These active-site His
modifications have been shown to result in the release of the catalyti-
cally-active metal ions, and subsequent unfolding and aggregation of
SOD1 [2,22]. To the best of our knowledge, the Zn ion coordinating His
residue, H64, has not been reported previously to be oxidized by MCO.
The modification of these three His residues (H47, H49, and H64),
which are critical to the structure and catalytic activity [23] could make
both the Cu and Zn metal ions labile, and promote SOD1 aggregation
through metal ion loss [22].
A third contributory factor to the protein destabilization maybe the
observed modifications to the electrostatic potential of the SOD1 sur-
face which has been suggested to maintain hydrogen bonding and salt-
bridge interactions [23]. The modification of five exposed Lys residues
(K70, K89, K97, K101, and K106; Fig. 6G, Table 2) may disrupt this
surface electrostatic potential and promote aberrant interactions that
nucleate aggregation. It is well established that various stressors and
mutations can destabilize native protein structures [93]. Although early
studies suggested that fully unfolded protein molecules could form
aggregates [94,95], recent evidence indicates that partially unfolded
states may be the key drivers of aggregate [96,97] and fibril [98,99]
formation. Thus, a modest increase in the population of partially-
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unfolded species may enhance the aggregation rate. Moreover, the toxic
gain-of-function in ALS has been proposed to occur via a partially un-
folded intermediate of SOD1 protein lacking metal-ion cofactors [100].
Thus, the detection in this study of partially unfolded ySOD1 con-
formations under various oxidative conditions may be of biological
significance.
4.5. Cu ion acts as a sacrificial substrate and partially folded ySOD1 species
retain enzymatic function
Consistent with the significant conformational changes that result
from oxidant exposure, the enzymatic activity of ySOD1 was found to
be reduced by around 50% under the mildest oxidative conditions ex-
amined (condition 1, Fig. 4B). This rapid loss of enzyme activity may be
attributed to the active site modifications discussed above. However, in
condition 2, which included exogenous Cu2+, an immediate loss of 60%
activity was observed followed by an increase in the activity after
5–60min (Fig. 4C). Such a reversal in ySOD1 enzymatic activity (Table
S4) is likely to be due to a reconstitution of Cu ions as these are present
in excess (Table 1). The addition of 142.5 μM Cu2+ in condition 1 had
less pronounced effects on the structure and activity (~50% of native
ySOD1 after 30min; Figs. 3B and 4B) than that induced by
950 μMH2O2 alone (Figs. 3A and 4A). This trend of Cu2+ protecting
against H2O2 was more distinct with higher concentrations of Cu2+
(285 μM) in condition 2, with both a higher level of ySOD1 activity
(> 70% of native ySOD1 after 30min, Fig. 4C), and less pronounced
effects on secondary structure, detected (Fig. 3C). Molecules including
xanthine, azide, imidazole, urate, and formate have been reported to
protect SOD1 against H2O2 induced inactivation, by either acting as a
sacrificial target or by reducing histidinyl radical intermediates
[67,72]. Thus, it is conceivable that free Cu2+ in the reaction mixture
reacts directly with excess H2O2, and thereby prevents reaction of H2O2
with enzyme-bound Cu2+. This suggestion is supported by the data
from condition 3 where the presence of 285 μM Cu2+ resulted in the
retention of 30% of the native ySOD1 activity compared to only ~5%
with 950 μMH2O2 alone after 180min (Fig. 4A and D). Copper-ion
loading of metal-ion deficient SOD1 has been proposed as a therapeutic
strategy against SOD1-associated ALS [101], and our observations lend
support to this hypothesis. Recent studies have employed diacetyl-bis
(4-methylthiosemicarbazonato)copper (II) complexes (CuIIATSM) to
deliver copper to the spinal cord tissue of Cu-deficient SOD1G37R mice.
It was postulated that the exogenous copper supplied by CuIIATSM to
partially folded intermediates of SOD1, might protect ALS transgenic
models expressing human Copper-Chaperone-for-SOD [101]. Further
studies have shown that CuIIATSM treatment can reduce the pool of Cu-
deficient SOD1 and increase the level of fully metallated (holo) SOD1
[102]. Improving the metal-ion content of SOD1 may therefore re-
present a valid therapeutic intervention against ALS induced by SOD1
mutations [101–104].
Although site-specific modification was investigated only for the
mildest oxidation conditions, it is conceivable that the loss of ySOD1
activity in conditions 3 and 5 (Fig. 4D and F) also stems from the de-
stabilization of the protein structure as detected in the CE and CD
analyses. Furthermore, the presence of AscH− (950 μM, condition 4)
protected against loss of SOD1 activity, indicating a protective role of
AscH− against oxidative protein dysfunction [20]. Although the loss-of-
function paradigm is not considered to be causative for ALS, a number of
FALS mutant SOD1 species have ~50% reduced activity in fibroblast,
lymphoblastoid and red blood cells [44,105]. Moreover, a loss-of-
function would result in impaired clearance of O2•− by less active
ySOD1 and may result in i) increased oxidative stress and, ii) a disease-
modifying toxic gain-of-function.
4.6. Disulfide bond oxidation: a protective mechanism against oxidant
damage?
The C58–C147 disulfide bond is an important structure stabilizing
factor in ySOD1 [35]. The disulfide bond is positioned ~10 Å from the
copper binding site in ySOD1 (see PDB structure 1B4L), with C147 more
solvent exposed than C58. The LC-MS peptide mapping data (Table 2)
obtained under condition 1 indicates that C147, but not C58, is subject
to oxidation within 0.1min, though this does not result in a massive
loss of enzymatic activity. ESI–MS spectra of intact ySOD1 show that a
series of distinct oxidation products have already been generated at the
0.1 min time point (Fig. 5B), with the first 7 oxidized peaks observed
(for the +15-charge state) having monoisotopic masses consistent with
the addition of 1–7 oxygen atoms. Based on peptide mapping by LC-
MS/MS these oxidation products are attributed to oxidation of M85,
C147 and possibly H47 and H49 (Table 2). The extent of oxidation
detected by ESI-MS after 0.1min under condition 3 is ~90% of the
parent protein, however, ~25% enzymatic activity was retained, in-
dicating that not all modifications result in a loss of activity. Earlier
studies have reported that cleavage of the disulfide bridge reduces the
activity to 5–10% of the native SOD [35]. The retained activity of
ySOD1 after MCO under condition 3 could indicate that the disulfide
bridge is not immediately cleaved by MCO. Consistent with this sug-
gestion, analysis of the LC-MS data from proteolytic digests performed
under non-reducing conditions revealed several oxidized forms of the
disulfide-containing dipeptide, but it was not possible to un-
ambiguously assign these mass shifts. However, the observation that a
peptide with oxidation of C147 to a sulfinic acid (138TGNAGPR-
PAC*GVIGLTN154) co-elutes with signals displaying spectral features of
a disulfide-linked peptide (Fig. 6D–F), may indicate that cleavage of the
disulfide bond occurs by in-source reduction in the mass spectrometer,
a phenomenon that has been reported previously, and not during the
initial MCO. These data, therefore, indicate that disulfide bond oxida-
tion may occur without cleavage of the -S-S- linkage in line with studies
carried out on low-molecular-mass disulfide-containing model com-
pounds and small peptides, where thiosulfinate and thiosulfonate (i.e.
RSS(O)R′ and RSS(O)2R’) formation has been detected [106–108]. We,
therefore, propose that this disulfide bond besides being a stabilizing
factor in ySOD1 also potentially protects ySOD1 against destructive
oxidation by acting as a sink for oxidative damage without a con-
comitant loss of enzymatic activity. The disulfide bond, like M85, may,
therefore, be an evolutionary-conserved protective mechanism in
ySOD1 that makes the enzyme more resistant to oxidative damage. The
proposed steps for the oxidation of the disulfide bond are shown in
Fig. 7. The idea of having protecting Met and Cys residues in SOD is not
new [109], but the observation that a disulfide bond might work in the
same way is novel.
5. Conclusions
This study shows that although SOD1 plays a major role in protec-
tion against oxidative damage in cells, it can also be readily modified by
moderate levels of oxidants. H2O2, the product of SOD1 catalysis, can
induce severe structural perturbations at pathophysiological con-
centrations. We have for the first time identified H64 (H63 in hSOD1)
as one of the major targets of copper ion catalyzed oxidation. This re-
sidue which acts as a ligand to both the Cu and Zn ions is located
outside of the active site β-barrel and is relatively exposed.
Modification of this residue could result in loss of both metal ions and
promote SOD1 dysfunction and unfolding. By analogy with ALS-causing
SOD1 mutations, which primarily affect the structural integrity of SOD1
protein [44] and initiate unfolding cascades, our data indicate that
early oxidation-induced modifications may result in the formation of
partially unfolded SOD1 species, and contribute to a vicious cycle of
loss-of-function and SOD1 aggregation through seeding. We propose
that the ability of ySOD1 to retain its function whilst continually
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exposed to reactive oxidants may be attributed to its evolutionary-
conserved disulfide bond which acts as a sink for oxidation equivalents
and ensures the structural and functional integrity of ySOD1. These
data may have bearing on the molecular events occurring in SOD1-as-
sociated ALS cases.
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